Understanding Emerging Treatment Strategies For R R Her2 Mbc
Let's dive into the details surrounding Emerging Treatment Strategies For R R Her2 Mbc. Adam M. Brufsky, MD, PhD, closes his discussion on advanced
Key Takeaways about Emerging Treatment Strategies For R R Her2 Mbc
- Recorded live around the latest data from SABCS, ASCO, and ESMO, this in-depth conversation features Dr. Mark Pegram and ...
- During this session, hear our speakers provide
- Wolfgang Janni, MD, PhD, University of Ulm, Ulm, Germany, discusses the second interim analysis of the Phase III DETECT V trial ...
- Using tucatinib in earlier lines of
- Leticia Varella, MD, and Adrienne Waks, MD discuss advances in research and
Detailed Analysis of Emerging Treatment Strategies For R R Her2 Mbc
In this episode, Dr. Adrienne Waks from the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute shares ... Rupert Bartsch, MD, Medical University Vienna, Vienna, Austria, gives an overview of the current standard of Dr. Kelly McCann, of the UCLA Health David Geffen School of Medicine, shares her expert insights on sequencing
emerging
That wraps up our extensive overview of Emerging Treatment Strategies For R R Her2 Mbc.
